ScoreWhy is Beta Drugs Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.95 times
2
The company has declared Positive results for the last 2 consecutive quarters
- OPERATING PROFIT TO INTEREST(Q) Highest at 10.69 times
- PBT LESS OI(Q) At Rs 20.46 cr has Grown at 61.61%
- NET SALES(Q) At Rs 125.55 cr has Grown at 25.29%
3
With ROE of 16.9, it has a Very Expensive valuation with a 10.8 Price to Book Value
- Over the past year, while the stock has generated a return of -100.00%, its profits have fallen by -9%
4
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -1.71% over the previous quarter and collectively hold 7.26% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Below par performance in long term as well as near term
- Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Beta Drugs Ltd should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Beta Drugs Ltd for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beta Drugs Ltd
44.87%
0.83
53.79%
Sensex
-1.65%
-0.12
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
27.10%
EBIT Growth (5y)
26.78%
EBIT to Interest (avg)
13.38
Debt to EBITDA (avg)
1.92
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
1.02
Tax Ratio
23.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.26%
ROCE (avg)
26.77%
ROE (avg)
53.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
10.75
EV to EBIT
45.35
EV to EBITDA
35.07
EV to Capital Employed
9.91
EV to Sales
6.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.86%
ROE (Latest)
16.95%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 10.69 times
PBT LESS OI(Q)
At Rs 20.46 cr has Grown at 61.61%
NET SALES(Q)
At Rs 125.55 cr has Grown at 25.29%
PBDIT(Q)
Highest at Rs 27.37 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.80%
PAT(Q)
Highest at Rs 15.80 cr.
EPS(Q)
Highest at Rs 14.25
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Beta Drugs Ltd
Operating Profit to Interest - Quarterly
Highest at 10.69 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.46 cr has Grown at 61.61%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 125.55 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 125.55 cr has Grown at 25.29%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 27.37 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.80%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 20.46 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 15.80 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 15.80 cr has Grown at 35.0%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 14.25
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
